SynthesisInflammopharmacology2025

Safety profile of glucokinase activator AZD1656: systematic review and meta-analysis of 23 randomised trials in diabetic and healthy volunteers with relevance to immunomodulatory therapy.

Mohamed M Elsayed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.